ISSN 1301 - 0883 / E-ISSN 1309 - 3886
 
 







 
 
Search





Investigation Of The Severity Of Depressive Symptoms In Cancer Patients Receiving Chemotherapy [Eastern J Med]
Eastern J Med. 2019; 24(4): 451-456 | DOI: 10.5505/ejm.2019.02419  

Investigation Of The Severity Of Depressive Symptoms In Cancer Patients Receiving Chemotherapy

Tülay Eren1, gökşen inanç İmamoğlu1, Cengiz Karaçin1, Sema Türker1, Ebru Cilbir1, hayriye Şahinli1, mustafa Altınbaş1, ramazan esen2, hasan Karadağ3, doğan yazılıtaş1
1University Of Health Sciences, Dışkapı Yıldırım Beyazıt Research And Training Hospital, Department Of Medical Oncology, Ankara, Turkey.
2Yuzuncu Yil University Faculty Of Medicine, Department Of Medical Oncology, Van, Turkiye.
3University of Health Sciences, Dışkapı Yıldırım Beyazıt Research and Training Hospital psychiatry department, Ankara, Turkey.

INTRODUCTION: The prevalance of depression is high in cancer patients. In the process of initiation, maintenance and completion of treatment, the detection of depression is closely associated with treatment outcomes. Therefore, awareness of this issue is of great significance at present. In view of the aforementioned information, The aim of the present study is to investigate the severity of depressive symptoms and factors that can lead to depression in cancer patients receiving outpatient chemotherapy.
METHODS: Patients receiving chemotherapy in Diskapi Training and Research Hospital and volunteering to participate in the study, were administered Beck Depression Inventory and asked to fill sociodemographic data form.
RESULTS: The present study was carried out with 100 patients (55 female, 45 male) receiving treatment in outpatient chemotherapy unit. High depression score was detected in 21 (%) patients. In the evaluation of the factors influencing high depression score, the rate of high depression score was found to be higher in female patients (p: 0.03). Similarly the rate of high depression score was higher in patients at metastatic stage (p: 0.01). Apart from these, no other factor was found to be associated with high depression score.
DISCUSSION AND CONCLUSION: Depression is one of the factors that affect treatment compliance and prognosis of the disease. Therefore, awareness of this issue is quite important. Cancer treatment requires a multidisciplinary approach and in this patient groups, those with depressive characteristics should be especially supported.

Keywords: Cancer Patient, Depression, Compliance with treatment


Tülay Eren, gökşen inanç İmamoğlu, Cengiz Karaçin, Sema Türker, Ebru Cilbir, hayriye Şahinli, mustafa Altınbaş, ramazan esen, hasan Karadağ, doğan yazılıtaş. Investigation Of The Severity Of Depressive Symptoms In Cancer Patients Receiving Chemotherapy. Eastern J Med. 2019; 24(4): 451-456

Corresponding Author: Tülay Eren, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Copyright © 2019 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale